Coma Clinical Trial
Official title:
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness - A Phase 1 Study
Phase 1 of the STIMPACT trial is an open label,dose-escalation,safety study of intravenous (IV) methylphenidate (MPH) therapy in patients with disorders of consciousness (DoC) caused by severe brain injuries. To be classified as having a DoC, a patient must be in a coma, vegetative state (VS), or minimally conscious state (MCS), as determined by behavioral assessment using the Coma Recovery Scale-Revised (CRS-R). Patients with DoC admitted to the intensive care unit (ICU) will be eligible for the study. A total of 10 patients with DoC will be enrolled in the Phase 1 study. Patients will receive escalating daily doses of IV MPH starting at 0.5 mg/kg, increasing stepwise to 1.0mg/kg and 2.0 mg/kg unless an adverse event (AE) necessitates dose de-escalation or a serious adverse event (SAE) necessitates that the patient stop participation in the study. Pharmacokinetics will be evaluated in selected patients with indwelling venous catheters or arterial catheters via serial serum measurements of MPH at each dose. The pharmacodynamic properties of IV MPH at each dose will be assessed by comparison of pre-versus post-dose EEG-based measures. The pharmacodynamic properties of the maximum tolerated dose will also be assessed by comparison of pre-versus post-dose resting state functional MRI (rs-fMRI) connectivity measures. Finally, we will test the association between structural connectivity of the ventral tegmental area (VTA), a dopaminergic brainstem nucleus that is believed to mediate MPH activation of the cerebral cortex, and EEG and rs-fMRI pharmacodynamic measures.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03504709 -
REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
|
||
| Completed |
NCT04772547 -
VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa
|
Phase 2 | |
| Withdrawn |
NCT00593164 -
Clinical Study of the LRS ThermoSuit™ System in Post Arrest Patients With Intravenous Infusion of Magnesium Sulfate
|
Phase 2 | |
| Completed |
NCT02486211 -
Amantadine to Speed Awakening After Cardiac Arrest
|
Phase 2 | |
| Active, not recruiting |
NCT01239420 -
Norwegian Cardio-Respiratory Arrest Study
|
||
| Not yet recruiting |
NCT04584463 -
Factors Associated With CPC 1-2 in 110 Patients Admitted in French ICU for a Myocardial Infarction Complicated by an OHCA.
|
||
| Recruiting |
NCT02338284 -
Optic Nerve Sheath Diameter as a Screening Test for Increased Intracranial Pressure
|
N/A | |
| Completed |
NCT00577954 -
Multimodal Resonance Imaging for Outcome Prediction on Coma Patients
|
N/A | |
| Recruiting |
NCT05861323 -
Feasibility of the Comfort Measures Only Time Out (CMOT)
|
N/A | |
| Not yet recruiting |
NCT06036732 -
A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
|
||
| Active, not recruiting |
NCT03826407 -
Development of a Point of Care System for Automated Coma Prognosis
|
||
| Completed |
NCT03616054 -
International Observational Study on Airway Management in Critically Ill Patients
|
||
| Completed |
NCT00573014 -
Cervical Spine Clearance in Obtunded Trauma Patients
|
N/A | |
| Completed |
NCT01973829 -
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
|
N/A | |
| Recruiting |
NCT06081283 -
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
|
Phase 4 | |
| Recruiting |
NCT05321459 -
Predictive Outcome in Comatose Patients
|
||
| Not yet recruiting |
NCT04623294 -
Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy
|
||
| Recruiting |
NCT04876222 -
Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma.
|
N/A | |
| Not yet recruiting |
NCT06321146 -
Evaluation of EEG Power Spectrum in Patients With Traumatic Coma
|
||
| Completed |
NCT03926494 -
Carbon Monoxide-induced Coma: Prognostic Factors
|